Most doctors tell you that there is no cure for Ataxia. It is true that there is no cure, however adult stem cells are available as a treatment option. Stem cell technology can offer you respite from the symptoms of ataxia and hopefully can bring you back to where you were a year or two ago. Many patients treated with our stem cells state they see benefits in their quality of life through the abatement of common ataxia-related symptoms: a more natural gait, improved fine motor skills, as well as clearer speech and thinking. Ataxia is one of the ailments that has been more successfully treated with Beikes umbilical cord blood stem cells based on patient satisfaction evaluations forms. This is why we have built this web site dedicated solely to Ataxia treatment information. Patients report that the treatment benefits often begin shortly after treatment and typically extend for 12-24 months. As with all treatments provided in the west, results vary by individual there are patients who have reported no improvement and there have been patients who have reported that the benefits have stayed with them for more than three years. Over 200 ataxia patients have been treated with stem … Continue reading →

Therapy for ataxic patients is multi-modal and involves persons from different disciplines and with different types of expertise. We advise patients with ataxia to work toward remaining in good general health by engaging in regular physical and mental exercise, eating and sleeping well, and avoiding injury from taking too much medicine, falling, or developing aspiration pneumonia. A primary care physician is essential for coordination of health care available for patients, encouragement of preventative health management, education of patients about avoidance of risks, and to guide the use of medications. Patients with ataxia benefit from interaction with a neurologist for multiple reasons, including establishment and confirmation of diagnoses, to follow the progression of ataxia, and to learn of associated neurological or psychiatric dysfunction for which therapy may be beneficial. Related signs and symptoms may include spasticity, tremor, fatigue, myoclonus, dystonia, peripheral neuropathy, seizures, thinking and memory difficulties, and personality or mood disorders. Pharmacological treatment has been beneficial in a small number of patients with specific ataxias and further research is ongoing worldwide. Examples of treatable ataxias include those due to deficiencies of vitamin E or coenzyme Q10 and Episodic Ataxia Type 2 (EA2), in which episodes of cerebellar dysfunction are reduced … Continue reading →

Nanomedicine is the medical application of nanotechnology that will hopefully lead to useful research tools, advanced drug delivery systems, and new ways to treat disease or repair damaged tissues and cells. Drug delivery is currently the most advanced application of nanotechnology in medicine. Nanoscale particles are being developed to improve drug bioavailability, a major limitation in the design of new drugs. Poor bioavailability is especially problematic with newer and still experimental RNA interference therapy. Lipid or polymer-based nanoparticles are taken up by cells due to their small size, rather than being cleared from the body. These nanoparticles can be used to shuttle drugs into cells which may not have accepted the drug on its own. The nanoparticle chaperone may also be able to specifically target certain cell types, possibly reducing toxicity and improving efficacy. Nanoparticles such as quantum dot nanocrystals are the size of a protein molecule or short stretch of DNA. Quantum dots can be engineered to absorb and emit many wavelengths of light with very sharp precision. This makes them ideal for protein-protein interaction studies as they can be linked to molecules to form long-lived probes. They can track biological events by tagging specific proteins or DNA in … Continue reading →

THURSDAY, Oct. 31 (HealthDay News) -- Early stem cell transplants do not improve overall survival in high-risk patients with aggressive non-Hodgkin's lymphoma, but may be beneficial for a small group of patients with the very highest risk, according to a new study. Non-Hodgkin's lymphoma is cancer of the white blood cells (lymphocytes). Larger-than-normal lymph nodes and fever are common symptoms. Many patients with this type of cancer relapse after undergoing chemotherapy and require an autologous stem cell transplant. In that procedure, the patient's own stem cells are removed before they receive high-dose chemotherapy and/or radiation. After the chemotherapy, the patient's stem cells are returned to help replenish the body's supply of blood cells. This study of 397 patients in the United States and Canada looked at whether giving patients a stem cell transplant before they relapsed would improve their chances of survival. The patients, who had an intermediate-high or high risk of relapse, were randomly assigned to receive an early stem cell transplant or to a "control group" that received three additional cycles of a five-drug chemotherapy regimen. After two years, 69 percent of those in the early transplant group had no disease progression, compared with 55 percent of those … Continue reading →

Vernon Hills, IL (PRWEB) November 01, 2013 Chicago Stem Cell Treatment Center, a research affiliate of Cell Surgical Network (CSN) provide stem cell therapy for a variety of degenerative conditions by deploying non-embryonic adult mesenchymal stem cells from a patients own adipose tissue or fat (also called Stromal Vascular Fraction (SVF)). The Stromal Vascular Fraction is a broth that contains stem cells and growth factors. We harvest and deploy Stromal Vascular Fraction (SVF) at our Vernon Hills, Illinois location. Your adipose derived adult stem cells are your body's natural healing cells. They are recruited by chemical signals emitted by damaged tissues to repair and regenerate your damaged cells. Under investigational protocols, adipose derived adult stem cells can be deployed to improve patients quality of life with a number of degenerative conditions and diseases. We use adipose derived mesenchymal stem cells for deployment & clinical research. Early stem cell therapy research has traditionally been associated with the controversial use of embryonic stem cells. The new focus is on non-embryonic adult mesenchymal stem cells which are found in a person's own blood, bone marrow and fat. Recent technological advances enable us to use adipose derived stem cells with our closed system to … Continue reading →